×

Agilent Technologies Gross Margin 2010-2025 | A

Current and historical gross margin for Agilent Technologies (A) over the last 10 years. The current gross profit margin for Agilent Technologies as of January 31, 2025 is %.
Agilent Technologies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-01-31 $6.53B $3.53B 53.97%
2024-10-31 $6.51B $3.54B 54.30%
2024-07-31 $6.50B $3.53B 54.39%
2024-04-30 $6.59B $3.34B 50.63%
2024-01-31 $6.74B $3.41B 50.56%
2023-10-31 $6.83B $3.47B 50.71%
2023-07-31 $6.99B $3.56B 50.93%
2023-04-30 $7.04B $3.84B 54.59%
2023-01-31 $6.93B $3.78B 54.55%
2022-10-31 $6.85B $3.72B 54.35%
2022-07-31 $6.66B $3.61B 54.21%
2022-04-30 $6.53B $3.52B 53.98%
2022-01-31 $6.45B $3.48B 53.98%
2021-10-31 $6.32B $3.41B 53.92%
2021-07-31 $6.14B $3.30B 53.65%
2021-04-30 $5.82B $3.11B 53.50%
2021-01-31 $5.53B $2.95B 53.38%
2020-10-31 $5.34B $2.84B 53.14%
2020-07-31 $5.22B $2.79B 53.34%
2020-04-30 $5.24B $2.81B 53.65%
2020-01-31 $5.24B $2.82B 53.88%
2019-10-31 $5.16B $2.81B 54.33%
2019-07-31 $5.09B $2.78B 54.54%
2019-04-30 $5.02B $2.74B 54.65%
2019-01-31 $4.99B $2.72B 54.48%
2018-10-31 $4.91B $2.68B 54.54%
2018-07-31 $4.81B $2.61B 54.25%
2018-04-30 $4.72B $2.55B 53.94%
2018-01-31 $4.62B $2.50B 54.05%
2017-10-31 $4.47B $2.40B 53.64%
2017-07-31 $4.39B $2.35B 53.48%
2017-04-30 $4.32B $2.30B 53.10%
2017-01-31 $4.24B $2.23B 52.68%
2016-10-31 $4.20B $2.20B 52.28%
2016-07-31 $4.13B $2.14B 51.96%
2016-04-30 $4.10B $2.12B 51.64%
2016-01-31 $4.04B $2.07B 51.11%
2015-10-31 $4.04B $2.04B 50.54%
2015-07-31 $4.81B $2.40B 49.98%
2015-04-30 $4.80B $2.39B 49.80%
2015-01-31 $4.83B $2.40B 49.65%
2014-10-31 $4.81B $2.39B 49.77%
2014-07-31 $4.72B $2.41B 50.92%
2014-04-30 $5.37B $2.76B 51.42%
2014-01-31 $6.11B $3.17B 51.80%
2013-10-31 $6.78B $3.54B 52.12%
2013-07-31 $6.83B $3.55B 51.95%
2013-04-30 $6.90B $3.58B 51.91%
2013-01-31 $6.90B $3.61B 52.30%
2012-10-31 $6.86B $3.60B 52.55%
2012-07-31 $6.82B $3.60B 52.84%
2012-04-30 $6.79B $3.61B 53.12%
2012-01-31 $6.73B $3.59B 53.29%
2011-10-31 $6.62B $3.53B 53.35%
2011-07-31 $6.46B $3.44B 53.26%
2011-04-30 $6.16B $3.28B 53.20%
2011-01-31 $5.75B $3.09B 53.67%
2010-10-31 $5.44B $2.93B 53.82%
2010-07-31 $5.04B $2.73B 54.22%
2010-04-30 $4.71B $2.54B 54.04%
2010-01-31 $4.53B $2.36B 52.19%
2009-10-31 $4.48B $2.29B 51.15%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.351B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00